project id: TCGA-STAD; case submitter id: TCGA-R5-A7O7; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.96; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.56; rna integrity number: 7.0; age at index: 51; days to birth: -18984; ethnicity: hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1959; age at diagnosis: 18984; ajcc pathologic m: M1; ajcc pathologic n: N1; ajcc pathologic stage: Stage IV; ajcc pathologic t: T3; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1389.0; icd 10 code: C16.0; last known disease status: not reported; morphology: 8211/3; primary diagnosis: Tubular adenocarcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cardia, NOS; synchronous malignancy: No; tissue or organ of origin: Cardia, NOS; tumor grade: Not Reported; year of diagnosis: 2010; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; weight: 5.0; composition: Not Reported; days to collection: 1010; days to sample procurement: 0; initial weight: 5.0; sample id: 7b5b06dd-e720-4738-bd33-1b87fbbd3cd7; sample submitter id: TCGA-R5-A7O7-01A; portion id: 03727d51-6c97-4eff-ae5e-123e2242830d; portion submitter id: TCGA-R5-A7O7-01A-11; slide id: 89156ac0-4a5f-481d-9d5a-76b3751585f7; slide submitter id: TCGA-R5-A7O7-01Z-00-DX1; percent lymphocyte infiltration: 15.0; percent monocyte infiltration: 2.0; percent necrosis: 0.0; percent neutrophil infiltration: 2.0; percent normal cells: 2.0; percent stromal cells: 35.0; percent tumor cells: 63.0; percent tumor nuclei: 77.0; section location: TOP;